T2 Biosystems, Inc. (TTOO)
USD 0.15
(-4.7%)
USD 0.15
(-4.7%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 62.83 Million USD | -15.5% |
| 2022 | 74.36 Million USD | 1.25% |
| 2021 | 73.44 Million USD | 4.39% |
| 2020 | 70.35 Million USD | 12.58% |
| 2019 | 62.49 Million USD | 18.08% |
| 2018 | 52.92 Million USD | -1.12% |
| 2017 | 53.52 Million USD | 6.55% |
| 2016 | 50.23 Million USD | 25.55% |
| 2015 | 40 Million USD | 54.95% |
| 2014 | 25.82 Million USD | -78.74% |
| 2013 | 121.42 Million USD | 63.89% |
| 2012 | 74.08 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 27.61 Million USD | -55.83% |
| 2024 Q1 | 62.52 Million USD | -0.49% |
| 2023 Q4 | 62.83 Million USD | 0.51% |
| 2023 Q3 | 62.51 Million USD | -15.0% |
| 2023 Q1 | 82.61 Million USD | 11.11% |
| 2023 Q2 | 73.55 Million USD | -10.97% |
| 2023 FY | 62.83 Million USD | -15.5% |
| 2022 Q2 | 77.12 Million USD | 3.26% |
| 2022 Q3 | 75.62 Million USD | -1.95% |
| 2022 Q4 | 74.36 Million USD | -1.67% |
| 2022 FY | 74.36 Million USD | 1.25% |
| 2022 Q1 | 74.69 Million USD | 1.7% |
| 2021 Q1 | 70.61 Million USD | 0.38% |
| 2021 Q3 | 72.5 Million USD | 3.74% |
| 2021 Q4 | 73.44 Million USD | 1.3% |
| 2021 Q2 | 69.88 Million USD | -1.03% |
| 2021 FY | 73.44 Million USD | 4.39% |
| 2020 Q3 | 60.05 Million USD | 3.36% |
| 2020 Q4 | 70.35 Million USD | 17.14% |
| 2020 FY | 70.35 Million USD | 12.58% |
| 2020 Q1 | 59.04 Million USD | -5.51% |
| 2020 Q2 | 58.1 Million USD | -1.6% |
| 2019 Q1 | 57.13 Million USD | 7.96% |
| 2019 FY | 62.49 Million USD | 18.08% |
| 2019 Q3 | 60.16 Million USD | -1.03% |
| 2019 Q2 | 60.79 Million USD | 6.4% |
| 2019 Q4 | 62.49 Million USD | 3.87% |
| 2018 Q1 | 52.2 Million USD | -2.46% |
| 2018 Q2 | 52.23 Million USD | 0.05% |
| 2018 Q3 | 52.13 Million USD | -0.19% |
| 2018 Q4 | 52.92 Million USD | 1.51% |
| 2018 FY | 52.92 Million USD | -1.12% |
| 2017 Q3 | 51.55 Million USD | 0.19% |
| 2017 FY | 53.52 Million USD | 6.55% |
| 2017 Q4 | 53.52 Million USD | 3.82% |
| 2017 Q2 | 51.45 Million USD | 3.67% |
| 2017 Q1 | 49.62 Million USD | -1.2% |
| 2016 Q2 | 43.25 Million USD | 8.54% |
| 2016 Q3 | 41.42 Million USD | -4.23% |
| 2016 Q4 | 50.23 Million USD | 21.27% |
| 2016 FY | 50.23 Million USD | 25.55% |
| 2016 Q1 | 39.84 Million USD | -0.4% |
| 2015 Q2 | 29.66 Million USD | 1.25% |
| 2015 Q1 | 29.29 Million USD | 13.45% |
| 2015 Q3 | 29.31 Million USD | -1.17% |
| 2015 Q4 | 40 Million USD | 36.48% |
| 2015 FY | 40 Million USD | 54.95% |
| 2014 Q4 | 25.82 Million USD | 48.08% |
| 2014 Q3 | 17.43 Million USD | -86.27% |
| 2014 Q2 | 127.03 Million USD | 761.11% |
| 2014 FY | 25.82 Million USD | -78.74% |
| 2014 Q1 | 14.75 Million USD | -87.85% |
| 2013 Q4 | 121.42 Million USD | 0.0% |
| 2013 FY | 121.42 Million USD | 63.89% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 74.08 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| OpGen, Inc. | 13.44 Million USD | -367.373% |